Wednesday 24 October 2012

Qnexa Side Effects

Qnexa Side Effects

The combination of the drugs phentermine and topiramate (trade name Qsymia, formerly Qnexa) is an investigational medication for the treatment of obesity and related conditions such as type 2 diabetes and has been found to lower blood pressure and cholesterol. Qsymia is being developed by Vivus, a California pharmaceutical company. Phentermine is an appetite suppressant and stimulant of the amphetamine and phenethylamine class. Topiramate is an anticonvulsant that has weight loss side effects. n 2009, Vivus reported that the main side effects during testing phases were dry mouth, a tingling in the fingers and toes and constipation. However, in 2010 Public Citizen's Dr. Sidney M. Wolfe testified before the FDA Advisory Committee that studies showed that Qnexa carries a long list of serious side effects, including possible birth defects. FDA approval was declined in October 2010 due to concerns about dangerous side effects, including suicidal thoughts, heart palpitations, memory lapses and birth defects.

Qnexa Side Effects

Qnexa Side Effects

Qnexa Side Effects

Qnexa Side Effects

Qnexa Side Effects

Qnexa Side Effects

Qnexa Side Effects

Qnexa Side Effects

Qnexa Side Effects


No comments:

Post a Comment